Brief: Osmotica Pharmaceuticals Says On Sept 8, Co Entered Into Sales Agreement With Cantor Fitzgerald & Co
08/09/2021 12:22
Sept 8 (Reuters) - Osmotica Pharmaceuticals PLC OSMT.O :
* OSMOTICA PHARMACEUTICALS SAYS ON SEPT 8, CO ENTERED INTO A
SALES
AGREEMENT WITH CANTOR FITZGERALD & CO - SEC FILING
* OSMOTICA PHARMACEUTICALS SAYS CO MAY OFFER AND SELL
ORDINARY
SHARES OF UP TO $75 MILLION THROUGH CANTOR AS ITS SALES AGENT
Source: [ID: https://bit.ly/3ha66fO]
Further company coverage: OSMT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RVL Pharmaceuticals
See all newsBrief: RVL Pharmaceuticals Says High Court Of Ireland Made A Winding Up Order In Respect Of Co On Feb 12
Brief: RVL Pharmaceuticals Says Co Issued Petition In Central Office Of High Court In Ireland To Wind Up Company
Brief: RVL Completes Financial Restructuring
Brief: Rvl Pharmaceuticals PLC Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius